Progressive supranuclear palsy samples were sequenced at FGC, IDOM and PGFI at University of Pennsylvania on the HiSeq2000/2500 machine.  705 samples were sequenced using Roche Nimblegen’s VCRome v2.1, target capture kit. BAM files from hg37 build and FASTQ files were sent to GCAD for processing on the VCPA1.1 pipeline. 549 passed sequencing metrics and quality control.

Total number of samples: 550

Female 249 45.3 %
Male 301 54.7 %

Total number of samples: 550

White550

Total number of samples: 550

Not Applicable/Not Available
550
100.0%

Total number of samples: 550

Disease
CBD10.2%
PSP54999.8%
Study Specific Diagnosis
Case550100.0%

Total number of samples: 550

  • NA550 (100.0%)